Reishi Mushroom and the Nervous System: What Researchers Are Studying

Published June 2026 · 10 min read

Reishi stands apart from most of what you encounter in the supplement world. It's quiet. Slow. It doesn’t announce itself with immediate energy or obvious stimulation. It's been used for centuries by people who measured wellness across seasons and lifetimes rather than afternoons.

In the modern research landscape, reishi (Ganoderma lucidum) has drawn the attention of neuroscientists and pharmacologists asking a careful question: does this mushroom, revered for millennia in East Asian medicine, have measurable effects on the nervous system? The answer, so far, is both promising and incomplete. That incompleteness deserves as much attention as the promise.

What follows is an honest look at what reishi contains, what researchers have explored, and where the evidence genuinely stands—respectful of tradition and transparent about science.

What Reishi Is

Ganoderma lucidum is a polypore mushroom with a woody, kidney-shaped cap and a lacquered, reddish-brown surface. It grows on deciduous hardwoods across Asia, Europe, and North America, though wild specimens are rare enough that nearly all commercially available reishi is cultivated.

In Traditional Chinese Medicine, reishi has been called língzhī—often translated as “mushroom of immortality.” The Shénnóng Běncǎo Jīng, a foundational text dating to the first or second century CE, classified reishi among the superior class of herbs—those considered safe for long-term use and believed to nourish life broadly. For over two thousand years, practitioners have associated it with calm, longevity, and spiritual clarity.

That history matters—not because ancient use proves modern efficacy, but because generations of careful observers found something worth returning to. When modern science encounters that sustained attention, it's worth asking why.

The Bioactive Compounds

Reishi isn't a single-compound mushroom. Its complexity is part of what makes it both interesting and difficult to study. Three classes of bioactive constituents have received the most attention:

Triterpenes and Ganoderic Acids

Reishi contains over 130 identified triterpenoid compounds, the most studied being the ganoderic acids—oxygenated lanostane-type triterpenes unique to the Ganoderma genus. Responsible for reishi’s characteristic bitter taste, they have drawn attention for anti-inflammatory, antioxidant, and potential neuromodulatory properties. In cell-based models, preclinical work has found that certain ganoderic acid derivatives mimic the activity of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), both of which promote neuronal survival.

Polysaccharides

Reishi’s polysaccharides—primarily beta-D-glucans—have been the focus of immunological research for decades. More recently, a 2017 study in Stem Cell Reports found that G. lucidum polysaccharides promoted neural progenitor cell proliferation in a mouse model, suggesting a potential role in neurogenesis pathways (Huang et al., 2017). This is preclinical work—a critical distinction we'll return to.

Peptidoglycans

Less studied than the triterpenes and polysaccharides, reishi’s peptidoglycans are protein-bound polysaccharides that may contribute to its immunomodulatory profile. Their specific neurological relevance remains largely unexplored.

What Researchers Are Exploring: Nervous System Support

The central research question is whether reishi’s traditional association with calm has identifiable biological mechanisms. Several preclinical lines of investigation suggest it might.

GABAergic Activity

The most directly relevant finding comes from a 2007 study in Pharmacology Biochemistry and Behavior. Researchers at Peking University found that a Ganoderma lucidum extract potentiated pentobarbital-induced sleep in rats via a GABAergic mechanism—decreasing sleep latency, increasing total sleeping time, and increasing non-REM sleep. Crucially, flumazenil, a benzodiazepine receptor antagonist, blocked these effects, suggesting reishi’s influence on sleep architecture may involve the same GABA-A receptor system targeted by pharmaceutical sleep aids (Chu et al., 2007).

This provides a plausible mechanism for reishi’s traditional use as a calming agent. But it's a rat study using a specific extract at specific doses, and the pathway from animal pharmacology to human relevance is long. (For another botanical with GABAergic research interest, see our article on passionflower and relaxation.)

Neuronal Health and Neuroprotection

A broader body of preclinical work has examined reishi’s potential to support neuronal health—including antioxidant defenses in neural tissue, neurotrophin activity, and inflammatory pathways. A 2023 review in Medical Research Reviews examined this evidence and concluded that while preclinical data is “encouraging,” crucial knowledge is still lacking (Luz et al., 2023). Most studies use different extracts, doses, and models, making unified conclusions difficult.

The Evidence Gap: What Honesty Requires

This is where the conversation requires candor. The gap between preclinical research and clinical evidence for reishi’s nervous system effects is real, and it's significant.

Most of what we have described comes from in vitro (cell culture) and in vivo (animal) studies. These establish biological plausibility and identify mechanisms worth investigating—but they aren't clinical evidence in humans. The history of pharmacology is full of compounds that showed preclinical promise and failed to translate.

A comprehensive 2021 review in Phytotherapy Research surveyed the totality of reishi research and concluded that “quality clinical data are intensely needed” (Ahmad et al., 2021). The clinical trials that do exist tend to focus on immune function rather than nervous system effects, and are generally small, short, and heterogeneous in extracts used.

If someone tells you reishi has been “proven” to support nervous system function, they're overstating the evidence. If someone says there's no reason to find reishi interesting for the nervous system, they're ignoring meaningful preclinical work and two millennia of traditional use. The truth sits between those positions, and holding that ambiguity honestly is more useful than resolving it prematurely.

Traditional Use and Modern Evidence: Different Conversations

Traditional use narratives and modern clinical evidence aren't the same category of knowledge. When TCM practitioners describe reishi as calming to the shen (spirit or mind), they work within a coherent framework rooted in centuries of observation. When a pharmacologist identifies GABAergic activity in a rat model, that's a different kind of knowing—mechanistic and powerful, but unable to capture the holistic context of traditional use.

Both perspectives suggest reishi may support a calm, balanced state. Neither has fully established this through randomized, placebo-controlled human trials. Respecting both means being clear about what each can and cannot tell us.

Reishi’s Broader Wellness Profile

While this article focuses on nervous system research, reishi has been explored across a wide range of wellness domains. The strongest human data concerns its potential to support immune function, where several clinical trials have explored immunomodulatory properties.

Many herbalists consider reishi an adaptogen—a substance that may help the body adapt to stress and maintain homeostasis. The adaptogen concept is debated in scientific circles, but it captures something traditional practitioners have long recognized: reishi seems to work broadly, supporting the body’s capacity for balance rather than pushing any single system in one direction. This broad profile is part of what makes reishi compelling in formulas designed around evening calm and recovery.

Why Reishi Anchors an Evening Calm Formula

Reishi isn't a sedative. It isn't melatonin. It doesn't force the body into sleep. What it may offer, based on the available evidence, is a gentle nudge toward the kind of physiological quiet that makes restful evenings more accessible—a role consistent with both its traditional profile and the developing preclinical picture.

This is why we chose reishi as the foundation of Reishi Relax Gummies, which pair 200 mg of reishi extract with L-theanine, lemon balm, passionflower, and valerian root. Each ingredient may support relaxation through complementary pathways—L-theanine for alpha brain wave activity, lemon balm and passionflower for their own traditional calm profiles, valerian as the subject of human sleep research for decades. Together, they represent a multi-pathway approach to evening unwinding.

For those who also want to support immune function as part of their evening routine, Reishi Calm Drops offer 150 mg of reishi alongside a 50 mg immune complex featuring chaga, maitake, shiitake, and turkey tail—because evening recovery isn't just about mental calm but also the time when the body does its deepest repair work.

Neither product claims to treat, cure, or prevent any disease. They offer carefully considered combinations of ingredients with meaningful traditional histories and developing research profiles, formulated for people who want to approach their evenings with intention.

References

1. Chu QP, Wang LE, Cui XY, et al. Extract of Ganoderma lucidum potentiates pentobarbital-induced sleep via a GABAergic mechanism. Pharmacol Biochem Behav. 2007;86(4):693-698. PMID: 17383716
2. Huang S, Mao J, Ding K, et al. Polysaccharides from Ganoderma lucidum promote cognitive function and neural progenitor proliferation in mouse model of Alzheimer’s disease. Stem Cell Reports. 2017;8(1):84-94. PMID: 28076758
3. Luz DA, Pinheiro AM, Fontes-Júnior EA, Maia CSF. Neuroprotective, neurogenic, and anticholinergic evidence of Ganoderma lucidum cognitive effects: crucial knowledge is still lacking. Med Res Rev. 2023;43(5):1504-1536. PMID: 37052237
4. Ahmad R, Riaz M, Khan A, et al. Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties. Phytother Res. 2021;35(11):6030-6062. PMID: 34411377